ACLY and autoimmune polyendocrinopathy: Anticardiolipin antibodies (aCL), along with anti-β2 glycoprotein I (a-β2GP1) and lupus anticoagulant, are key markers of APS, an autoimmune condition characterized by recurrent thrombotic events and/or pregnancy morbidity (39).